Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study.

@article{Lotan2014CannabisM,
  title={Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study.},
  author={Itay Lotan and Therese A. Treves and Yaniv Roditi and Ruth Djaldetti},
  journal={Clinical neuropharmacology},
  year={2014},
  volume={37 2},
  pages={
          41-4
        }
}
OBJECTIVE The use of cannabis as a therapeutic agent for various medical conditions has been well documented. However, clinical trials in patients with Parkinson disease (PD) have yielded conflicting results. The aim of the present open-label observational study was to assess the clinical effect of cannabis on motor and non-motor symptoms of PD. METHODS Twenty-two patients with PD attending the motor disorder clinic of a tertiary medical center in 2011 to 2012 were evaluated at baseline and… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 42 CITATIONS

Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience

VIEW 4 EXCERPTS
CITES RESULTS

Evidence for the use of cannabinoids in Parkinson’s disease

VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Cannabinoid analgesia. Pharmacol Ther 2002;95:127–135. www.clinicalneuropharm.com 43 thorized reproduction of this article is prohibited

  • J Walker, S. Huang
  • Lotan et al Clinical Neuropharmacology • Volume 37, Number
  • 2014

Cannabinoid pharmacology

  • WL Dewey
  • Pharmacol Rev 1986;38:151–178. © 2014 Lippincott Williams & Wilkins thorized reproduction of this article is prohibited
  • 2014

Unau model of Parkinson ’ s disease

  • O Harris
  • Behav Brain Res
  • 2009